Jianmei W. Leavenworth

MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 18 papers. Top paper: “Remodeling of the tumor microenvironment via disrupting Blimp1+ effector Treg activity augments response to anti-PD-1 blockade”.

Remodeling of the tumor microenvironment via disrupting Blimp1+ effector Treg activity augments response to anti-PD-1 blockade

Molecular Cancer(2021)10.1186/s12943-021-01450-3

N/A

0DataRank · unranked

60 citations

Lin Luo, Sadashib Ghosh, Jeffrey M Grimes, Jonathan D. Leavenworth, Jianmei W. Leavenworth +1 more

RNF2 ablation reprograms the tumor-immune microenvironment and stimulates durable NK and CD4+ T-cell-dependent antitumor immunity

Nature Cancer(2021)10.1038/s43018-021-00263-z

N/A

0DataRank · unranked

32 citations

Lin Luo, Chuan Xing, Yu Chen, Peng Xu, Li Mao +12 more

Positron emission tomography imaging with 89Zr-labeled anti-CD8 cys-diabody reveals CD8+ cell infiltration during oncolytic virus therapy in a glioma murine model

Scientific Reports(2021)10.1038/s41598-021-94887-x

N/A

0DataRank · unranked

28 citations

Hailey Houson, Jennifer Coleman, Jianmei W. Leavenworth, James M. Markert, Anna M. Wu +8 more

Dysregulated follicular regulatory T cells and antibody responses exacerbate experimental autoimmune encephalomyelitis

Journal of Neuroinflammation(2021)10.1186/s12974-021-02076-4

N/A

0DataRank · unranked

25 citations

Xianzhen Hu, Michael Dixon, Brandon J. Pope, Jonathan D. Leavenworth, Chander Raman +3 more

Lineage Reprogramming of Effector Regulatory T Cells in Cancer

Frontiers in Immunology(2021)10.3389/fimmu.2021.717421

N/A

0DataRank · unranked

23 citations

Jonathan D. Leavenworth, Jianmei W. Leavenworth, Michael Dixon

Author Correction: Positron emission tomography imaging with 89Zr-labeled anti-CD8 cys-diabody reveals CD8+ cell infiltration during oncolytic virus therapy in a glioma murine model

Scientific Reports(2021)10.1038/s41598-021-00042-x

N/A

0DataRank · unranked

1 citations

Hailey Houson, Jennifer Coleman, Jianmei W. Leavenworth, James M. Markert, Anna M. Wu +8 more

Immune Activity and Response Differences of Oncolytic Viral Therapy in Recurrent Glioblastoma: Gene Expression Analyses of a Phase IB Study

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-21-2636

N/A

0DataRank · unranked

38 citations

Kevin A. Cassady, Justin C. Roth, Jennifer Clements, Kathleen M. Schieffer, Kristen Leraas +9 more

Contribution of Dysregulated B-Cells and IgE Antibody Responses to Multiple Sclerosis

Frontiers in Immunology(2022)10.3389/fimmu.2022.900117

N/A

0DataRank · unranked

22 citations

Monica M. Moran, Jonathan D. Leavenworth, Jianmei W. Leavenworth, Malik R. Seals

Structure–Activity Relationship Study of Momordica Saponin II Derivatives as Vaccine Adjuvants

Journal of Medicinal Chemistry(2022)10.1021/acs.jmedchem.2c01087

N/A

0DataRank · unranked

7 citations

Di Bai, Sadashib Ghosh, Michael L. Franks, Xifeng Wang, Cheng Yan +6 more

Targeting the TREM1-positive myeloid microenvironment in glioblastoma

Neuro-Oncology Advances(2022)10.1093/noajnl/vdac149

N/A

0DataRank · unranked

13 citations

Jeffrey M Grimes, Jianmei W. Leavenworth, David Namkoong, Xiuhua Yang, Peter H. King +4 more

Editorial: Immune Cell Lineage Reprogramming in Cancer

Frontiers in Immunology(2022)10.3389/fimmu.2021.838464

N/A

0DataRank · unranked

5 citations

Lewis Z. Shi, Xi Wang, Haiming Wei, Jianmei W. Leavenworth

Data from Immune Activity and Response Differences of Oncolytic Viral Therapy in Recurrent Glioblastoma: Gene Expression Analyses of a Phase IB Study

(2023)10.1158/1078-0432.c.6531350

N/A

0DataRank · unranked

0 citations

Kevin A. Cassady, Justin C. Roth, Jennifer N. Clements, Kathleen M. Schieffer, Kristen Leraas +9 more

Data from Immune Activity and Response Differences of Oncolytic Viral Therapy in Recurrent Glioblastoma: Gene Expression Analyses of a Phase IB Study

(2023)10.1158/1078-0432.c.6531350.v1

N/A

0DataRank · unranked

0 citations

Kevin A. Cassady, Justin C. Roth, Jennifer N. Clements, Kathleen M. Schieffer, Kristen Leraas +9 more

The Role of Natural Killer Cells in Oncolytic Virotherapy: Friends or Foes?

Vaccines(2024)10.3390/vaccines12070721

N/A

0DataRank · unranked

10 citations

Ju-Hyun An, Jianmei W. Leavenworth, Michael L. Franks

Oncolytic virotherapy augments self-maintaining natural killer cell line cytotoxicity against neuroblastoma

Cancer Immunology Immunotherapy(2024)10.1007/s00262-024-03818-y

N/A

0DataRank · unranked

6 citations

Janet R. Julson, Hooper R. Markert, Nazia Nazam, Swatika Butey, Jerry E. Stewart +5 more

Oncolytic reprogramming of tumor microenvironment shapes CD4 T-cell memory via the IL6ra-Bcl6 axis for targeted control of glioblastoma

Nature Communications(2025)10.1038/s41467-024-55455-9

N/A

0DataRank · unranked

22 citations

Sadashib Ghosh, Shamza Manzoor, Li Xin Li, Monica M. Moran, Jennifer C. Clements +4 more

Mutations in MLL3 promote breast cancer progression via HIF1α-dependent intratumoral recruitment and differentiation of regulatory T cells

Immunity(2025)10.1016/j.immuni.2025.07.008

N/A

0DataRank · unranked

8 citations

Kenta Nishitani, Nicole Couturier, Piril Erler, Zheng Zhang, Anna Maria Militello +14 more

Emerging role of follicular regulatory T-cells in neuroimmunological disorders

Current Opinion in Immunology(2025)10.1016/j.coi.2025.102584

N/A

0DataRank · unranked

1 citations

Qisen Guo, Jianmei W. Leavenworth, Stephen Yaw Opoku